The Trade Sanctions Reform and Export Enhancement Act of 2000 (TSRA)
TSRA is Title IX of Public Law 106-387, signed into law on October 28, 2000. Its core function is straightforward: it provides that the President shall terminate any unilateral agricultural sanction or unilateral medical sanction in effect as of the date of enactment. In plain terms, the U.S. had been using sanctions to block the sale of food and medical goods to certain countries, and TSRA directed that those particular restrictions be lifted.
What it covers — and what it doesn’t
The goods covered are agricultural commodities, medicine, and medical devices. The definition of agricultural commodities is broad: it includes food commodities, feed, fish, shellfish and fish products, beer, wine and spirits, soft drinks, livestock, fiber including cotton, wool and other fibers, tobacco and tobacco products, wood and wood products including lumber and utility poles, seeds, and reproductive materials. However, the term does not include furniture made from wood, clothing manufactured from plant or animal materials, agricultural equipment, pesticides, insecticides, herbicides, or cosmetics unless derived entirely from plant materials.
The lifting of sanctions is not unlimited. TSRA does not direct the termination of any unilateral agricultural or medical sanction that prohibits, restricts, or conditions the use of any agricultural commodity, medicine, or medical device that is controlled on the United States Munitions List, controlled on any control list established by the Export Administration Act of 1979 or any successor statute, or used to facilitate the development or production of chemical or biological weapons or weapons of mass destruction.
Which countries are affected, and how
The law operates differently depending on the country involved. Section 906(a)(1) requires that an export licensing requirement apply to sales to those countries that the Secretary of State has determined have repeatedly provided support for acts of international terrorism — in practice, Cuba, Iran, and Sudan. Though the Secretary of State has also determined that the governments of North Korea and Syria are sponsors of international terrorism, Section 906(a)(2) explicitly states that the license requirement does not apply to sales to those two countries.
For Iran specifically, OFAC applies the licensing procedures required by Section 906 of the TSRA to all exports and reexports of agricultural commodities, medicine, and medical devices to Iran, covering exports to the government, any entities in the country, individuals in the country, and persons in third countries purchasing specifically for resale to any of the foregoing. These licenses are issued for one-year periods.
The financing restrictions
Alongside the licensing requirement, TSRA imposes strict limits on how these transactions can be paid for. No U.S. government assistance — including foreign assistance, export assistance, and any U.S. credit or guarantees — shall be available for exports to Cuba or for commercial exports to Iran, Libya, North Korea, or Sudan, though the President may waive this for the latter four countries on national security or humanitarian grounds. For Cuba specifically, exports can only be paid in cash-only sales that are paid in advance and must be financed by third-country financial institutions. The statute further specifies that nothing in the financing provisions authorizes payment terms or trade financing involving a debit or credit to an account of a person located in Cuba or of the Government of Cuba maintained on the books of a United States depository institution.
The quarterly reporting requirement
TSRA’s Section 906(b) requires OFAC to report periodically to Congress on the licenses it has processed. Under the procedures established in its TSRA-related regulations, OFAC processes license applications requesting authorization to export agricultural commodities, medicine, and medical devices to Iran under the specific licensing regime set forth in Section 906 of the TSRA. The quarterly report referenced in the OFAC update you processed covers activities undertaken from October through December 2025, and is a direct fulfillment of this statutory reporting obligation.
Sudan’s current status
Worth noting as a practical update: as of December 14, 2020, no license from OFAC is required for exports or reexports of agricultural commodities, medicine, or medical devices to Sudan or the Government of Sudan, or for financing such exports or reexports, meaning Sudan has effectively been moved out of the specific licensing regime, leaving Iran as the primary country to which the active TSRA licensing process currently applies.
